Inspire Medical Systems, Inc. Stock 12‑Month Price Target Raised to $69.44, Implies 3% Upside

What happened

Sixteen analysts raised the average 12-month price target for Inspire Medical Systems to $69.44 from $68, with forecasts ranging from $40 to $97 per share. Based on the November 2 closing price, that target implies about 3% possible upside. The consensus rating stays Hold across 19 analysts, with 4 Buys, 11 Holds and 4 Sells.

Confirmed

Global impact / market context

A higher average target means analysts on balance expect slightly more value per share than before, though the small 3% gain suggests limited optimism. The Hold rating and the wide $40 to $97 range show analysts disagree about the company's prospects, so investors should expect mixed views rather than a clear direction.

Analyst inference

The average target rose modestly, pointing to gradual analyst adjustments rather than a major shift in expectations. With most analysts at Hold, the balance of opinion is cautious, and the broad forecast range signals uncertainty about future performance.

Analyst inference

What to watch

1. Watch whether the average price target of $69.44 continues rising and whether the $40 to $97 range narrows, since a tighter range would show analysts moving toward a shared view of the stock. Confirmed
2. A useful step is comparing the next average target with the November 2 closing price to see if the roughly 3% implied upside grows or shrinks over time. Proposed
3. Track changes in the analyst mix of 4 Buys, 11 Holds and 4 Sells, because a shift toward more Buys or Sells would signal growing confidence or concern about the company. Analyst inference

Evidence

• Original source link unavailable